Edge Wealth Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Hold |
25,000
| – | – | 0.04% | 73 |
|
|
2025
Q1 | $196K | Buy |
25,000
+5,000
| +25% | +$39.2K | 0.04% | 76 |
|
|
2024
Q4 | $210K | Hold |
20,000
| – | – | 0.04% | 74 |
|
|
2024
Q3 | $262K | Buy |
+20,000
| New | +$262K | 0.05% | 65 |
|
|
2024
Q2 | – | Sell |
-40,000
| Closed | -$676K | – | 79 |
|
|
2024
Q1 | $676K | Sell |
40,000
-110,000
| -73% | -$1.86M | 0.14% | 42 |
|
|
2023
Q4 | $2.12M | Hold |
150,000
| – | – | 0.46% | 29 |
|
|
2023
Q3 | $1.55M | Hold |
150,000
| – | – | 0.36% | 33 |
|
|
2023
Q2 | $2.47M | Sell |
150,000
-20,000
| -12% | -$330K | 0.54% | 32 |
|
|
2023
Q1 | $1.55M | Hold |
170,000
| – | – | 0.36% | 33 |
|
|
2022
Q4 | $1.19M | Buy |
170,000
+14,000
| +9% | +$98K | 0.28% | 39 |
|
|
2022
Q3 | $795K | Hold |
156,000
| – | – | 0.18% | 43 |
|
|
2022
Q2 | $381K | Buy |
156,000
+11,000
| +8% | +$26.9K | 0.08% | 58 |
|
|
2022
Q1 | $990K | Hold |
145,000
| – | – | 0.2% | 48 |
|
|
2021
Q4 | $1.17M | Hold |
145,000
| – | – | 0.21% | 47 |
|
|
2021
Q3 | $1.42M | Buy |
145,000
+15,000
| +12% | +$147K | 0.28% | 50 |
|
|
2021
Q2 | $881K | Hold |
130,000
| – | – | 0.18% | 57 |
|
|
2021
Q1 | $1.18M | Buy |
130,000
+30,000
| +30% | +$271K | 0.25% | 53 |
|
|
2020
Q4 | $679K | Buy |
100,000
+40,000
| +67% | +$272K | 0.15% | 62 |
|
|
2020
Q3 | $302K | Buy |
+60,000
| New | +$302K | 0.07% | 88 |
|